David Enloe, Recro Pharma CEO

Mov­ing be­yond just sol­id dose, Re­cro Phar­ma is head­ed to San Diego with ac­qui­si­tion

Penn­syl­va­nia-based CD­MO Re­cro Phar­ma is ex­pand­ing to the West Coast with the ac­qui­si­tion of Irisys, a San Diego CD­MO.

The com­pa­ny an­nounced the deal Fri­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.